Clearance of Pneumocystis carinii in Mice Is Dependent on B Cells But Not on P. carinii-Specific Antibody 1
暂无分享,去创建一个
[1] Arturo Casadevall,et al. CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. , 2002, Immunity.
[2] C. Haidaris,et al. Passive Intranasal Monoclonal Antibody Prophylaxis against Murine Pneumocystis carinii Pneumonia , 2002, Infection and Immunity.
[3] J. Cyster,et al. Splenic T Zone Development Is B Cell Dependent , 2001, The Journal of experimental medicine.
[4] Y. Ron,et al. Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations. , 2001, International immunology.
[5] J. Shellito,et al. CD4+ T cell-independent vaccination against Pneumocystis carinii in mice. , 2001, The Journal of clinical investigation.
[6] J. Standing,et al. Vitronectin and fibronectin function as glucan binding proteins augmenting macrophage responses to Pneumocystis carinii. , 2001, American journal of respiratory cell and molecular biology.
[7] R. Zinkernagel,et al. IgA production without μ or δ chain expression in developing B cells , 2001, Nature Immunology.
[8] S. Swain,et al. Reciprocal regulation of polarized cytokine production by effector B and T cells , 2000, Nature Immunology.
[9] J. Volanakis,et al. Complement-Dependent Acute-Phase Expression of C-Reactive Protein and Serum Amyloid P-Component1 , 2000, The Journal of Immunology.
[10] M. Shlomchik,et al. Dual infection with Pneumocystis carinii and Pasteurella pneumotropica in B cell-deficient mice: diagnosis and therapy. , 2000, Comparative medicine.
[11] A. Limper,et al. Alveolar macrophage interactions with Pneumocystis carinii. , 1999, The Journal of laboratory and clinical medicine.
[12] H. Ochs,et al. Enteroviral meningoencephalitis as a complication of X-linked hyper IgM syndrome. , 1999, The Journal of pediatrics.
[13] M. Lepore,et al. Pneumocystis carinii pneumonia in an infant with X-linked agammaglobulinemia. , 1998, The Journal of allergy and clinical immunology.
[14] S. Kaufmann,et al. Activated Pulmonary Macrophages Are Insufficient for Resistance against Pneumocystis carinii , 1998, Infection and Immunity.
[15] R. Flavell,et al. CD40 and CD154 in cell-mediated immunity. , 1998, Annual review of immunology.
[16] B. Garvy,et al. CONTENT ALERTS , 1997 .
[17] A. Fischer,et al. Clinical spectrum of X-linked hyper-IgM syndrome. , 1997, The Journal of pediatrics.
[18] X. Qin,et al. Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamsters. , 1997, The Journal of clinical investigation.
[19] J. Standing,et al. The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung. , 1997, The Journal of clinical investigation.
[20] P. Kvale,et al. Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort. Pulmonary Complications of HIV Infection Study Group. , 1997, American journal of respiratory and critical care medicine.
[21] B. Garvy,et al. Antibody-mediated shift in the profile of glycoprotein A phenotypes observed in a mouse model of Pneumocystis carinii pneumonia , 1996 .
[22] H. Marcotte,et al. Pneumocystis carinii infection in transgenic B cell-deficient mice. , 1996, The Journal of infectious diseases.
[23] J. Sun,et al. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. , 1996, Immunity.
[24] D. Gray,et al. CD40 ligand-transduced co-stimulation of T cells in the development of helper function , 1995, Nature.
[25] R. Flavell,et al. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand , 1995, Nature.
[26] R. Flavell,et al. Rapid induction of a novel costimulatory activity on B cells by CD40 ligand , 1995, Current Biology.
[27] A. Harmsen,et al. CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice. , 1995, Journal of immunology.
[28] F. Gigliotti,et al. Active immunity to Pneumocystis carinii reinfection in T-cell-depleted mice , 1995, Infection and immunity.
[29] J. Standing,et al. Pneumocystis carinii glycoprotein A binds macrophage mannose receptors , 1995, Infection and immunity.
[30] C. Janeway,et al. Induction of B cell costimulatory function by recombinant murine CD40 ligand , 1994, European journal of immunology.
[31] S. Goodwin. Pneumocystis carinii Pneumonia in Human Immunodeficiency Virus‐Infected Infants and Children , 1993, Pharmacotherapy.
[32] J. Standing,et al. Pneumocystis carinii stimulates tumor necrosis factor-alpha release from alveolar macrophages through a beta-glucan-mediated mechanism. , 1993, Journal of immunology.
[33] J. Shellito,et al. Host defenses against Pneumocystis carinii in mice selectively depleted of CD4+ lymphocytes. , 1993, Chest.
[34] C. Sidman,et al. Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice. , 1992, The Journal of clinical investigation.
[35] A. Harmsen,et al. T cells are not sufficient for resistance to Pneumocystis carinii pneumonia in mice. , 1991, The Journal of protozoology.
[36] D. Williams,et al. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor , 1991, Nature.
[37] S. J. Hayes,et al. Geosmin As an Odorous Metabolite In Cultures of A Free‐Living Amoeba, Vannella Species (Gymnamoebia, Vannellidae) , 1991 .
[38] H. Rugo,et al. Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. , 1990, International immunology.
[39] A. Harmsen,et al. Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice , 1990, The Journal of experimental medicine.
[40] W. Hughes,et al. Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models. , 1988, The Journal of clinical investigation.
[41] J. Sprent,et al. T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes. , 1987, Journal of immunology.
[42] C. Janeway,et al. The B cell is the initiating antigen-presenting cell in peripheral lymph nodes. , 1987, Journal of immunology.
[43] D. Gajdusek. Pneumocystis carinii; etiologic agent of interstitial plasma cell pneumonia of premature and young infants. , 1957, Pediatrics.